Compare WGS & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WGS | ATEC |
|---|---|---|
| Founded | 2017 | 1990 |
| Country | United States | United States |
| Employees | 1300 | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | N/A | 2006 |
| Metric | WGS | ATEC |
|---|---|---|
| Price | $56.46 | $8.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $120.71 | $22.00 |
| AVG Volume (30 Days) | 1.2M | ★ 2.3M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | $29.98 | $18.97 |
| Revenue Next Year | $25.92 | $16.70 |
| P/E Ratio | $1,251.58 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $32.21 | $6.82 |
| 52 Week High | $170.87 | $23.29 |
| Indicator | WGS | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 51.16 | 48.87 |
| Support Level | $32.21 | $7.27 |
| Resistance Level | $73.46 | $8.42 |
| Average True Range (ATR) | 4.21 | 0.38 |
| MACD | 1.05 | 0.15 |
| Stochastic Oscillator | 42.45 | 70.07 |
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.